These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11528165)

  • 1. A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barré syndrome.
    Diener HC; Haupt WF; Kloss TM; Rosenow F; Philipp T; Koeppen S; Vietorisz A;
    Eur Neurol; 2001; 46(2):107-9. PubMed ID: 11528165
    [No Abstract]   [Full Text] [Related]  

  • 2. A Novel Treatment Strategy for Severe Guillain-Barré Syndrome: Zipper Method.
    Kesici S; Tanyıldız M; Yetimakman F; Bayrakci B
    J Child Neurol; 2019 Apr; 34(5):277-283. PubMed ID: 30696330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin".
    Buenz EJ
    J Clin Neurosci; 2009 Aug; 16(8):1110; author reply 1111. PubMed ID: 19467870
    [No Abstract]   [Full Text] [Related]  

  • 4. Apheresis and selective adsorption plus immunoglobulin treatment in Guillain-Barré syndrome.
    Haupt WF; Birkmann C; van der Ven C; Pawlik G
    Ther Apher; 2000 Jun; 4(3):198-200. PubMed ID: 10910019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment and prognosis of Guillain-Barré syndrome].
    Mitsui T; Nomura K
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():381-7. PubMed ID: 26480729
    [No Abstract]   [Full Text] [Related]  

  • 6. Guillain-Barré syndrome following chickenpox: a case series.
    Tatarelli P; Garnero M; Del Bono V; Camera M; Schenone A; Grandis M; Benedetti L; Viscoli C
    Int J Neurosci; 2016; 126(5):478-9. PubMed ID: 26000930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasmapheresis for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Odaka M
    Nihon Rinsho; 2004 May; 62 Suppl 5():491-5. PubMed ID: 15197970
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Guillain-Barré Syndrome].
    Nomura K
    Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome.
    Ansar V; Valadi N
    Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Guillain-Barré syndrome: a cost-effectiveness analysis.
    Nagpal S; Benstead T; Shumak K; Rock G; Brown M; Anderson DR
    J Clin Apher; 1999; 14(3):107-13. PubMed ID: 10540364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Guillain-Barré syndrome.
    McNair ND
    J Infus Nurs; 2013; 36(6):397-400. PubMed ID: 24202119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances of therapeutic apheresis in Guillain-Barré syndrome.
    Haupt WF
    Ther Apher; 2000 Aug; 4(4):271-4. PubMed ID: 10975472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling Guillain-Barré syndrome.
    Castro MC
    Nurs Manage; 2010 Aug; 41(8):36-9; quiz 39-40. PubMed ID: 20671533
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional outcomes following inpatient rehabilitation of Guillain-Barré syndrome patients: Intravenous immunoglobulins versus plasma exchange.
    Bondi M; Engel-Haber E; Wolff J; Grosman-Rimon L; Bloch A; Zeilig G
    NeuroRehabilitation; 2021; 48(4):543-551. PubMed ID: 34024788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
    Fokke C; van den Berg B; Drenthen J; Walgaard C; van Doorn PA; Jacobs BC
    Brain; 2014 Jan; 137(Pt 1):33-43. PubMed ID: 24163275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison on therapeutic effect of plasma exchange and intravenous immunoglobulin for Guillian-Barre syndrome.
    Ye Y; Li SL; Li YJ
    Transfus Med; 2015 Apr; 25(2):79-84. PubMed ID: 25515056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome.
    Pritchard J
    Clin Med (Lond); 2010 Aug; 10(4):399-401. PubMed ID: 20849020
    [No Abstract]   [Full Text] [Related]  

  • 20. Guillain-Barré syndrome in general practice: clinical features suggestive of early diagnosis.
    Head VA; Wakerley BR
    Br J Gen Pract; 2016 Apr; 66(645):218-9. PubMed ID: 27033501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.